Ovarian hyperstimulation syndrome (Q45044): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Doença do sistema endócrino, causada por níveis séricos elevados do hormônio gonadotrofina coriônica humana, comumente após o uso de tratamentos injetáveis para fertilidade. Esta doença é caracterizada por aumento ovariano e complicações hemodinâmicas ou metabólicas. Essa doença também pode se manifestar com dor abdominal, distensão abdominal ou ganho de peso, dependendo dos sintomas graduais.
description / endescription / en
 
A disease of the endocrine system, caused by elevated human chorionic gonadotropin hormone, commonly after the use of injectable fertility treatments. This disease is characterised by ovarian enlargement, and hemodynamic or metabolic complications. This disease may also present with abdominal pain, abdominal bloating, or weight gain depending on graded symptoms.

Revision as of 12:51, 13 August 2026

A disease of the endocrine system, caused by elevated human chorionic gonadotropin hormone, commonly after the use of injectable fertility treatments. This disease is characterised by ovarian enlargement, and hemodynamic or metabolic complications. This disease may also present with abdominal pain, abdominal bloating, or weight gain depending on graded symptoms.
Language Label Description Also known as
default for all languages
GA32.0
    English
    Ovarian hyperstimulation syndrome
    A disease of the endocrine system, caused by elevated human chorionic gonadotropin hormone, commonly after the use of injectable fertility treatments. This disease is characterised by ovarian enlargement, and hemodynamic or metabolic complications. This disease may also present with abdominal pain, abdominal bloating, or weight gain depending on graded symptoms.

      Statements